Drugs / lopinavir/ritonavir
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04434248 Comparator | Apr → Jul 2020 | COVID-19 | Chromis LLC | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lopinavir/ritonavir | “Hydroxychloroquine, chloroquine, lopinavir/ritonavir, etc.” NCT04434248 ↗ |